@article { author = {Singh, Shalendra and Chandran, CR Sarath and Kr Paul, Shamik and Hota, Rabi Narayan}, title = {A Case of COVID‑19 with Recent Surgery for Subdural Hematoma – A Therapeutic Thromboprophylaxis Dilemma}, journal = {Archives of Trauma Research}, volume = {10}, number = {4}, pages = {235-236}, year = {2021}, publisher = {Kashan University of Medical Sciences}, issn = {2251-953X}, eissn = {2251-9599}, doi = {}, abstract = {Dear Sir,The practice of preemptively administering therapeutic doses of low‑molecular‑weight heparin (LMWH) to prevent the dreaded complication of venous thromboembolism in COVID‑19 cases is practiced globally.[1,2] LMWH increases the chances of bleeding, but since COVID‑19 causes a relative prothrombotic state, it is needed to administer LMWH in such cases. Chronic subdural hematoma (cSDH) is one of the most common surgical interventions in daily neurosurgical procedures in which mortality and morbidity vary with urgency and postoperative complications. The risk of recurrent hematoma after cSDH is 5%–30% within a span of 2–3 months.[3] An anticoagulant drug like LMWH is a known risk factor for cSDH. The use of anticoagulants in severe COVID‑19 patients in postoperative cSDH is controversial. Here, we present a clinical dilemma to initiate LMWH in a patient suffering from severe COVID‑19 infection in postoperative cSDH surgery.}, keywords = {}, url = {https://archtrauma.kaums.ac.ir/article_156284.html}, eprint = {https://archtrauma.kaums.ac.ir/article_156284_adffe186d0702c407533bbcf84208cc8.pdf} }